Characterization of prostate cancers potentially amenable to tyrosine kinase inhibitors of platelet derived growth factor receptor

被引:0
|
作者
Fecko, A [1 ]
Shen, RL [1 ]
Chinnaiyan, AM [1 ]
Rubin, MA [1 ]
机构
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
675
引用
收藏
页码:149A / 149A
页数:1
相关论文
共 50 条
  • [31] Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC
    Pallis, A. G.
    Syrigos, K. N.
    LUNG CANCER, 2013, 80 (02) : 120 - 130
  • [32] Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    James M. Rae
    Marc E. Lippman
    Breast Cancer Research and Treatment, 2004, 83 : 99 - 107
  • [33] Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors
    Ghatalia, Pooja
    Morgan, Charity J.
    Choueiri, Toni K.
    Rocha, Pedro
    Naik, Gurudatta
    Sonpavde, Guru
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 136 - 145
  • [34] Pharmacophore analysis of epidermal growth factor receptor tyrosine kinase inhibitors
    Peng, T
    Pei, JF
    Zhou, JJ
    ACTA CHIMICA SINICA, 2003, 61 (03) : 430 - 434
  • [35] Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different?
    Rukazenkov, Yuri
    Speake, Georgina
    Marshall, Gayle
    Anderton, Judith
    Davies, Barry R.
    Wilkinson, Robert W.
    Hickinson, D. Mark
    Swaisland, Alan
    ANTI-CANCER DRUGS, 2009, 20 (10) : 856 - 866
  • [36] Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Kao, Steven C.
    Boyer, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (27) : 3233 - 3234
  • [37] Epidermal growth factor receptor tyrosine kinase inhibitors in cancer therapy
    Adjej, AA
    DRUGS OF THE FUTURE, 2001, 26 (11) : 1087 - 1092
  • [38] Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors
    Rae, JM
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (02) : 99 - 107
  • [39] Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents
    Ciardiello, F
    DRUGS, 2000, 60 (Suppl 1) : 25 - 32
  • [40] Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity
    Dietmar Gross
    Günther Bernhardt
    Armin Buschauer
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 589 - 599